Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
CAR-TCR Summit Europe 2021 and Car Tcr Summit Europe 2021
View overview page
2:49
Exciting advances in CAR-T and TCR research
David Gilham
• 22 Feb 2021
1:40
Innovations within the CAR T-cell field
Hong Ma
• 19 Feb 2021
2:56
Allogenic NKX101 in r/r AML
James Trager
• 22 Feb 2021
6:05
Selecting TCRs: understanding peptide-HLA-TCR interactions
Dolores Schendel
• 25 Feb 2021
8:28
Investigating allogeneic iNKT cell therapy
Marc van Dijk
• 23 Feb 2021
6:34
Combining iNKT and CAR technology
Marc van Dijk
• 23 Feb 2021
3:23
How the TCR field can learn from CARs
Dolores Schendel
• 25 Feb 2021
5:11
PD1-41BB switch receptor expression in the treatment of PD-L1-positve solid tumors
Dolores Schendel
• 25 Feb 2021
3:05
Targetting cancer with allogeneic NK cell therapies
James Trager
• 10 Mar 2021
2:09
CAR-NKs for B cell malignancies
James Trager
• 10 Mar 2021
1:45
Automated cell culture in cell & gene therapy
Dalip Sethi
• 23 Feb 2021
3:24
CYAD-101 & alloSHRINK: allogeneic CAR-T cell therapy in MSS mCRC
David Gilham
• 22 Feb 2021
4:15
CT053, anti-GPC3 CAR-T and targeting solid tumors
Hong Ma
• 19 Feb 2021
2:43
Automation in cell therapy manufacturing: enhancing the fill and finish step
Dalip Sethi
• 23 Feb 2021
3:28
Analysing trends in the CAR-TCR landscape
Vasiliki Zochiou
• 22 Feb 2021
2:29
CYCLE-1: next generation NKG2D-based CAR T-cells in AML/MDS
David Gilham
• 22 Feb 2021
1
2
Next